Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
13,291 total articles
BlackLine, Inc. announced solid financial results for the first quarter of 2026, with 9.7% revenue growth year over year to $183.2 million, improved GAAP and non-GAAP operating margins, and increased net income. The company highlighted the commercial adoption of its AI-driven platform capabilities and raised its full-year financial guidance, expect…
Adaptive Biotechnologies reported a 35% year-over-year revenue increase to $70.9 million in Q1 2026, driven primarily by a 53% growth in its Minimal Residual Disease (MRD) business. The company enhanced its full-year MRD revenue guidance to $260-270 million. Despite a net loss of $20 million, this was an improvement compared to the prior year, with…
Cricut, Inc. announced its first quarter 2026 financial results with revenue of $159.5 million, down 2% year-over-year, and net income of $20.3 million, down 15% year-over-year. The company reported growth in its platform revenue by nearly 6% and an increase in paid subscribers to just under 3.08 million. International revenue rose over 16%, making…
Trevi Therapeutics announced strong first quarter 2026 financial results, highlighted by a $162 million net cash infusion from a follow-on stock offering, ensuring funding through 2030. The company is progressing on multiple clinical fronts for its investigational drug Haduvio in treating IPF-related chronic cough, non-IPF ILD-related chronic cough…
Talen Energy Corporation reported a robust first quarter 2026 with GAAP net income of $63 million, adjusted EBITDA of $473 million, and adjusted free cash flow of $350 million—substantial year-over-year improvements. The company reaffirmed its 2026 financial guidance ranges and announced a definitive agreement to acquire three power plants in India…
Korro Bio, a biopharmaceutical company specializing in RNA editing through its OPERA® platform, announced that key executives will participate in the HCW 4th Annual BioConnect Nasdaq Investor Conference and the 2026 RBC Capital Markets Global Healthcare Conference. These engagements aim to present their innovative genetic medicine programs and stra…
Caribou Biosciences announced that its CEO, Dr. Rachel Haurwitz, will participate in a fireside chat at the upcoming Bank of America Securities 2026 Health Care Conference. The company is a clinical-stage biopharmaceutical firm specializing in CRISPR genome-editing for therapies targeting hematologic malignancies with off-the-shelf CAR-T cell treat…
ServiceTitan, a software platform specializing in AI-driven solutions for trade contractors, announced it will release its fiscal first quarter 2027 financial results on June 4, 2026, followed by a conference call to discuss the results and fiscal year 2027 outlook. The company provides AI-powered workflow automation for contracting businesses acro…
Alamar Biosciences, a leader in Precision Proteomics, announced it will present at the BofA Securities 2026 Healthcare Conference, showcasing its NULISA technology and ARGO HT System aimed at early disease detection through biomarker analysis.
American Coastal Insurance Corporation reported net income of $19.3 million for Q1 2026, slightly down 9.8% year-over-year. Gross premiums written fell 24.5% to $149.4 million due to a softening commercial insurance market and pricing pressure. The company maintained solid underwriting discipline with a combined ratio of 66.0%. Book value per share…
MYR Group Inc., a leading specialty electrical contractor in the U.S. and Canada, will participate in the Baird Global Consumer, Technology & Services Conference on June 4, 2026, to meet with institutional investors and present its business operations across the electric utility infrastructure and commercial-industrial construction markets.
Spero Therapeutics, a clinical-stage biopharmaceutical company focused on rare diseases and high unmet needs, plans to release its Q1 2026 financial results and provide a business update on May 13, 2026, after market close. No conference call is scheduled.
Weyco Group, Inc. announced first quarter 2026 financial results with net sales steady at $68 million compared to Q1 2025. Operating earnings rose by 7%, and net earnings increased by 10%, driven by improved cost controls despite tariff-related cost pressures. The company is actively engaging in a tariff refund process following a Supreme Court rul…
Sana Biotechnology, a US-based biotech company specializing in engineered cell therapies, announced it will present a business overview and company updates at the BofA Securities 2026 Healthcare Conference on May 12, 2026. The presentation by CEO Steve Harr will detail Sana's strategy and vision for advancing gene and cell therapies. The webcast wi…
OnKure Therapeutics reported Q1 2026 financial results highlighting a strategic focus on next-generation PI3Kα pan-mutant selective inhibitors, OKI-355 for vascular anomalies and OKI-345 for breast cancer. The company completed an oversubscribed $150 million private placement, boosting cash reserves to $192 million, expected to fund operations into…
Verrica Pharmaceuticals announced the presentation of Phase 2 clinical data highlighting the potential abscopal effects of their novel oncolytic peptide VP-315 in treating basal cell carcinoma (BCC). The data suggest VP-315 can reduce untreated tumor lesions, indicating broader immune activation that may benefit patients with multiple BCC lesions. …
CarGurus, a leading online automotive platform, has entered a multi-year partnership with NASCAR Canada as a Presenting Partner and the Official Automotive Marketplace. The agreement includes CarGurus becoming the entitlement partner for two races, starting with the CarGurus 200 at Canadian Tire Motorsport Park. This collaboration aims to enhance b…
LeMaitre Vascular, a US-based vascular device and implant company, announced robust Q1 2026 financial results featuring an 11% increase in sales to $66.6 million, a 42% rise in EPS to $0.68, and a gross margin improvement to 72.7%. The company cited growth across all major product lines and geographical regions, supported by higher prices and manuf…
Devon Energy Corp., a leading U.S. oil and gas producer, reported its first-quarter 2026 financial and operational results and issued an outlook for the second quarter of 2026. The company highlighted its multi-basin portfolio, including a key position in the Delaware Basin, and reaffirmed its commitment to strong returns, free cash flow generation…
Supernus Pharmaceuticals (NASDAQ: SUPN) reported a 39% year-over-year increase in total revenues to $207.7 million for Q1 2026, driven by 56% growth in revenues from its four growth products including Qelbree, GOCOVRI, ZURZUVAE, and ONAPGO. The company highlighted ongoing clinical development programs, a potential FDA submission for a second ONAPGO…
Postal Realty Trust, Inc., a REIT specializing in properties leased primarily to the USPS, declared a quarterly dividend of $0.245 per share for Q1 2026, marking a 1% increase from the prior year. This reflects the company's stable income stream and confidence in continued occupancy by USPS tenants.
Standard BioTools Inc. reported first quarter 2026 financial results with revenue of $21.1 million, a 5% increase year-over-year. The company achieved a 54% reduction in operating loss and a 78% improvement in adjusted EBITDA, reinforcing its path to profitability by the end of 2026. Cash and investments totaled $524 million, supporting an aggressi…
InnovAge Holding Corp., a leading provider of healthcare programs to frail, predominantly dual-eligible seniors, announced their financial results for the fiscal third quarter ended March 31, 2026. The company reported increased revenues and improved center-level contribution margin, alongside a larger net loss compared to the prior year period. In…
Relay Therapeutics reported strong first quarter 2026 results, highlighted by the FDA granting Breakthrough Therapy designation to its lead drug zovegalisib for PIK3CA-mutant HR+/HER2- advanced breast cancer. The company also presented promising clinical data supporting the progression of its zovegalisib plus atirmociclib triplet combination in fro…
Rapid7, Inc. announced its Q1 2026 financial results, reporting annualized recurring revenue (ARR) of $832 million and total revenue of $210 million, slightly down year-over-year. The company posted a GAAP loss from operations of $0.6 million but a non-GAAP operating income of $24 million, with net cash provided by operating activities of $40 milli…
